Cadrenal Therapeutics Inc... (CVKD)
NASDAQ: CVKD
· Real-Time Price · USD
12.60
-0.32 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
12.69
0.71%
After-hours: Aug 15, 2025, 06:19 PM EDT
Cadrenal Therapeutics Common Stock Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
Cash & Equivalents | 5.57M | 7.34M | 10.02M | 4.36M | 5.04M | 6.57M | 8.4M | 9.11M | 3.23M | 4.03M | 32.59K | 103.08K | 59.65K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2.17K | 3.79K | 3.79K | 3.79K | 175.18K | 171.63K | 3.79K | 3.79K | 3.79K | 3.79K | -526.01K | 2.19K | 2.19K |
Receivables | 19.04K | 24.66K | 38.15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 382.22K | 8.45K | 14.45K | 116.88K | n/a | n/a | n/a | n/a | n/a | n/a | 672.29K | 414.24K | 153.81K |
Total Current Assets | 5.97M | 7.94M | 10.11M | 4.67M | 5.27M | 6.86M | 8.49M | 9.28M | 3.52M | 4.44M | 727.6K | 541.36K | 241.15K |
Property-Plant & Equipment | 4.28K | 4.68K | 6.94K | 3.01K | 9.88K | 16.61K | 23.29K | 29.78K | 36.1K | 39K | 44.59K | 1.77K | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 6.44K | 8.47K | 10.74K | 6.8K | 185.05K | 188.25K | 27.08K | 33.57K | 39.89K | 42.79K | 50.58K | 3.97K | 2.19K |
Total Assets | 5.98M | 7.95M | 10.12M | 4.68M | 5.46M | 7.05M | 8.52M | 9.31M | 3.56M | 4.48M | 778.17K | 545.32K | 243.35K |
Account Payables | 895.61K | 1.28M | 1.5M | 496.82K | 759.52K | 400.37K | 167.32K | 141.66K | 78.14K | 119.57K | 404.9K | 308.22K | 207.5K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | 8.8K | n/a | 21.35K | 24.99K | 24.06K | n/a | 43.73K | n/a | n/a |
Other Current Liabilities | 311.94K | 424.36K | 966.58K | 767.89K | 428.23K | 230.87K | 574.78K | 330.54K | 210.8K | 170.28K | 605.29K | n/a | n/a |
Total Current Liabilities | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M | 856.32K | 826.88K | 563.57K | 374.31K | 401.63K | 1.33M | 672.36K | 339.71K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 553.34K | 528.47K | 424.96K |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.42M | 524.31K | 149.52K |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.23K | 8.8K | 15.17K | 4.99M | 1.05M | 574.48K |
Total Liabilities | 1.68M | 1.84M | 2.68M | 1.27M | 1.46M | 856.32K | 826.88K | 565.8K | 383.1K | 416.8K | 6.33M | 1.73M | 914.18K |
Total Debt | n/a | n/a | n/a | 2.23K | 8.8K | 15.17K | 21.35K | 27.22K | 32.86K | 38.33K | 640.71K | 528.47K | 424.96K |
Common Stock | 2.01K | 1.91K | 1.78K | 1.23K | 16.01K | 16.01K | 13.02K | 13.02K | 11.72K | 11.72K | 8.19K | 8.13K | 7.95K |
Retained Earnings | -33.24M | -29.57M | -25.72M | -21.54M | -19.13M | -16.73M | -15.07M | -13.93M | -12.89M | -11.89M | -6.71M | -1.7M | -678.79K |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 4.3M | 6.11M | 7.44M | 3.41M | 3.99M | 6.19M | 7.69M | 8.75M | 3.18M | 4.07M | -5.55M | -1.18M | -670.84K |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |